Adams Helen C. 4
4 · Prometheus Biosciences, Inc. · Filed May 20, 2022
Insider Transaction Report
Form 4
Adams Helen C.
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-05-19+21,526→ 21,526 totalExercise: $29.02Exp: 2032-05-18→ Common Stock (21,526 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest in full upon the earlier to occur of (i) the first anniversary of the grant date or (ii) the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer on such vesting date.